Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent
Manuel Yepes, Maria Sandkvist, Timothy A. Coleman, Elizabeth Moore, Jiang-Young Wu, David Mitola, Thomas H. Bugge, Daniel A. Lawrence
Manuel Yepes, Maria Sandkvist, Timothy A. Coleman, Elizabeth Moore, Jiang-Young Wu, David Mitola, Thomas H. Bugge, Daniel A. Lawrence
View: Text | PDF
Article Genetics

Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent

  • Text
  • PDF
Abstract

Tissue-type plasminogen activator (tPA) is a highly specific serine proteinase expressed in the CNS during events that require neuronal plasticity. In this study we demonstrate that endogenous tPA mediates the progression of kainic acid–induced (KA-induced) seizures by promoting the synchronization of neuronal activity required for seizure spreading, and that, unlike KA-induced cell death, this activity is plasminogen-independent. Specifically, seizure induction by KA injection into the amygdala induces tPA activity and cell death in both hippocampi, and unilateral treatment of rats with neuroserpin, a natural inhibitor of tPA in the brain, enhances neuronal survival in both hippocampi. Inhibition of tPA within the hippocampus by neuroserpin treatment does not prevent seizure onset but instead markedly delays the progression of seizure activity in both rats and wild-type mice. In tPA-deficient mice, seizure progression is significantly delayed, and neuroserpin treatment does not further delay seizure spreading. In contrast, plasminogen-deficient mice show a pattern of seizure spreading and a response to neuroserpin that is similar to that of wild-type animals. These findings indicate that tPA acts on a substrate other than plasminogen and that the effects of neuroserpin on seizure progression and neuronal cell survival are mediated through the inhibition of tPA.

Authors

Manuel Yepes, Maria Sandkvist, Timothy A. Coleman, Elizabeth Moore, Jiang-Young Wu, David Mitola, Thomas H. Bugge, Daniel A. Lawrence

×

Figure 6

Options: View larger image (or click on image) Download as PowerPoint
Analysis of tPA activity in brain extracts. (a) SDS-PAGE zymography of b...
Analysis of tPA activity in brain extracts. (a) SDS-PAGE zymography of brain extracts. Lane 1 is a mixture of human tPA and a rat kidney extract as a marker for rat urokinase plasminogen activator (uPA). Lane 2 is empty, and lanes 3–10 are hippocampal extracts 1 hour after KA injection. Lanes 3, 5, 7, and 9 are ipsilateral (I) and lanes 4, 6, 8, and 10 are contralateral (C) to the injection. Lanes 3 and 4 are from sham-operated animals that did not receive KA (Sham), and all other lanes show animals that received KA. Lanes 5 and 6 show PBS-treated animals, lanes 7 and 8 are from neuroserpin-treated animals (Ns), and lanes 9 and 10 are from animals that underwent corpus callosotomy (Call). (b) Quantitative analysis of PA activity from SDS-PAGE zymography of brain extracts 1 hour after KA injection. The results represent the average fold increase in tPA activity in the hippocampus ipsilateral (Ipsi) and contralateral (Contra) to the KA injection, relative to normal base-line tPA activity in sham-operated animals. PBS and Ns represent animals treated with PBS or neuroserpin, respectively (n = 5 for each condition), and Call represents brain extracts of animals that underwent corpus callosotomy (n = 2). *P < 0.05 relative to PBS-treated animals. AU, arbitrary units.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts